In contrast to sCr, urinary L-FABP concentrations in the AKI+ group showed rapid increase, as early as 2 h after receiving CIS-CT, and were significantly higher by Hour 6 than in the AKI− group. The gene discussed is FABP1; the disease is in situ carcinoma.